Celgene completes purchase of Former Merck Property

- Celgene Corporation has completed its purchase of the former Merck & Co., Inc. property located at 556 Morris Ave. The property features 850,000 square feet of administrative office space, and 450,000 square feet of Research & Development space.

The acquisiton by Summit-headquartered Celgene, an integrated, global pharmaceutical company, extends the company’s existing Hilltop City presence beyond its 86 Morris Ave. global headquarters location. 

Combined with the completion of construction of a new 550,000-squar- foot office building at its 86 Morris Ave. location, the purchase allows Celgene to concentrate its New Jersey operations at two campuses in close proximity in Summit.
 
“This acquisition marks an important milestone in our company’s growth in New Jersey and our long relationship as a proud resident of Summit,” said Bob Hugin, Chairman and CEO of Celgene,  “A vibrant biopharmaceutical sector benefits patients, the healthcare system, and our local communities. With this new site, and the soon to be completed new building at our headquarters location, we are building an even stronger presence in this great community.”

Read more here. 

Up Next:


Up Next

  • Celgene completes purchase of Former Merck Property
  • Woman, child seriously injured by falling tree in Central Park
  • Small plane crashes in western Connecticut
  • Student killed by log during football training
  • Now an adult, former Boy Scout speaks out about alleged abuse
  • Cyclist robbing cabbies in Manhattan
  • Cheetos-inspired pop-up restaurant coming to NYC
  • Tiny baby born at 12 ounces finally goes home after nearly 5 months in NICU
  • Family claims daughter being held by R. Kelly hires legal team
  • Huge pot bust worth half a million dollars in Rockdale County